MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
1.340
-0.090
-6.29%
After Hours: 1.400 +0.06 +4.48% 18:48 05/15 EDT
OPEN
1.400
PREV CLOSE
1.430
HIGH
1.500
LOW
1.330
VOLUME
956.32K
TURNOVER
--
52 WEEK HIGH
1.915
52 WEEK LOW
0.5068
MARKET CAP
74.79M
P/E (TTM)
-1.9802
1D
5D
1M
3M
1Y
5Y
1D
PDS Biotechnology Earnings Call Highlights Trial Acceleration
TipRanks · 2d ago
Analysts’ Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)
TipRanks · 3d ago
PDS Biotech outlines VERSATILE-003 amendment targeting interim PFS with approximately 250 patients
Seeking Alpha · 3d ago
PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript
Benzinga · 3d ago
Earnings Scheduled For May 13, 2026
Benzinga · 3d ago
PDS Biotechnology GAAP EPS of -$0.13
Seeking Alpha · 3d ago
PDS Biotech Q1 FY26 net loss narrows to $7.3 million; R&D expenses drop to $3.5 million
PUBT · 3d ago
PDS Biotechnology Q1 net loss narrows
Reuters · 3d ago
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.